Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have been awarded a $1.72 million grant from the National Institutes of Health to support the Neuro-Oncology Translational ...

The FDA makes furthering moves in SCLC, ovarian, and breast cancers, and the value of remote clinical pharmacists is explored in community oncology.

Men undergoing radiation therapy for prostate cancer who experience side effects early in treatment may face a higher risk of developing more serious long-term urinary and bowel health issues, ...

NIH’s plan to cut what it pays universities and other entities for indirect costs associated with scientific research would ...

Kishan, who is also an investigator at the UCLA Health Jonsson Comprehensive Cancer Center, emphasized the potential impact of newer techniques to reduce both acute and late toxicities.

of the UCLA Health Jonsson Comprehensive Cancer Center in Los Angeles, in the statement. "With a median progression-free survival [PFS] exceeding 1 year and a response rate of more than 60% ...